July 12, 2007 - Clinicians at Providence Holy Cross Cancer Center are currently using an advanced form of image-guided radiation therapy (IGRT), that combines imaging and treatment techniques in a single machine, from Varian Medical Systems to treat patients with breast, prostate, head and neck, lung and gynecological cancers.

The combined technique, reportedly provides fast and accurate radiotherapy that maximizes the dose to the tumor and reduces the side effects of treatment.

"This new approach to treating cancer makes it possible for us to fine-tune our targeting so that we can do a better job of protecting the surrounding tissues during treatment," said Nancy Ellerbroek, MD, medical director for radiation oncology at the Center.

According to Ellerbroek, having the ability to generate images on a daily basis is reassuring when she is delivering high doses of radiation to tumors close to critical structures in the body. "It allows me to deliver the powerful doses we know are better at eradicating tumors without cutting corners because we're afraid of getting too close to something crucial," she said. "That means we can target tumors we would have considered untreatable just a year ago. I expect our tumor control rates will improve and our complication rates will be lower, when we've had a chance to study IGRT outcomes over a longer period of time. So far, our experience bears this out."

For more information: www.varian.com, providence.org


Related Content

News | Image Guided Radiation Therapy (IGRT)

June 7, 2022 — Two-year results from the Dysphagia-Aspiration Related Structures (DARS) trial, which is funded by Cancer ...

Time June 07, 2022
arrow
News | Image Guided Radiation Therapy (IGRT)

May 19, 2022 — Brainlab announced that clinicians at UZ Brussel are the first to treat patients with the company’s new ...

Time May 19, 2022
arrow
News | Radiation Oncology

August 27, 2021 — For decades, the National Comprehensive Cancer Network (NCCN) recommended forgoing post-lumpectomy ...

Time August 27, 2021
arrow
News | Radiation Therapy

June 10, 2020 — A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides ...

Time June 10, 2020
arrow
News | Radiation Therapy

April 16, 2020 — RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy ...

Time April 16, 2020
arrow
News | Image Guided Radiation Therapy (IGRT)

February 11, 2020 — Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive ...

Time February 11, 2020
arrow
News | Radiology Imaging

December 12, 2019 — Philips and the Regional Medical Center (RMC) announced a strategic 5-year partnership agreement ...

Time December 12, 2019
arrow
News | Radiation Therapy

October 22, 2019 — The American Society for Radiation Oncology (ASTRO) and the American College of Radiology (ACR) ...

Time October 22, 2019
arrow
News | Image Guided Radiation Therapy (IGRT)

ViewRay Inc. announced today that patient treatments are scheduled to begin in Boston with ViewRay's MRIdian Linac System at Dana-Farber/Brigham and Women's Cancer Center. The MRIdian provides for the delivery of radiation therapy to targeted tumors while simultaneously providing continuous magnetic resonance imaging (MRI).

Time October 08, 2019
arrow
News | Image Guided Radiation Therapy (IGRT)

At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, being held Sept. 15-18 in Chicago, Varian announced Ethos therapy, an artificial intelligence (AI)-driven holistic solution designed to increase the capability, flexibility and efficiency of radiotherapy. This new solution is designed to deliver an entire adaptive treatment in a typical 15-minute timeslot, from patient setup through treatment delivery.

Time September 16, 2019
arrow
Subscribe Now